Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial

Abstract Background Viral load (VL) testing is key in monitoring adherence to antiretroviral therapy (ART) and documenting HIV treatment response. As per HIV treatment guidelines in Uganda, the first VL test is recommended 6 months after initiation of ART. Undetectable VL (uVL) at ART initiation may...

Full description

Bibliographic Details
Main Authors: Grace Gabagaya, Gordon Rukundo, Alexander Amone, Priscilla Wavamunno, Joyce Namale-Matovu, Irene Lubega, Clemensia Nakabiito, Zikulah Namukwaya, Monica Nolan, Samuel S. Malamba, Rachel King, Jaco Homsy, Mary Glenn Fowler, Philippa Musoke
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Infectious Diseases
Subjects:
HIV
Online Access:https://doi.org/10.1186/s12879-021-06608-4